Reply  by Mullens, Wilfried et al.
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August 11, 2009:661–8tudy that there were no renal hemodynamic differences between
iuretics and ultrafiltration.
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eply
e appreciate the enthusiastic interests and insightful comments
egarding our report on the potential role of venous congestion as
driver for worsening renal function (WRF) in patients admitted
ith advanced decompensated heart failure (ADHF) (1). We have
cknowledged in the report that many factors can contribute in the
athophysiology of WRF in the setting of ADHF. While our
xisting data cannot demonstrate direct causation between elevated
entral venous pressure and WRF, our current treatment goals are
o reduce filling pressures and to improve cardiac output using a
ide range of drug and device therapies according to protocols
stablished in our heart failure intensive care unit. It is important
o clarify that the mean dosages of furosemide during intensive
edical therapy were similar among patients who did and did not
evelop WRF, with similar percentages of patients in both groups
eceiving furosemide through continuous parental infusion. While
he biggest hemodynamic determinant of the subsequent develop-
ent of WRF in this patient population with initially depressed
ardiac index appeared to be elevated central venous pressure rather
han low cardiac output, we believe our data supported the
resence of venous congestion as the driver of the process, either
ue to underlying restrictive physiology, overzealous diuretic use,
eurohormonal up-regulation, or more likely the severity of
ongestion. Dissecting these factors may be challenging in the
linical setting, and may vary widely among individual patients.
egardless, this is a clear departure from the traditional “cardio-
entric” concept of impaired cardiac output as the primary deter-
inant of cardio-renal compromise in some patients with ADHF.
Contrary to animal experiments, we did not observe a direct
orrelation between baseline renal function and severity of venous
ongestion; several reasons might account for this discrepancy.
irst, the duration and onset of venous congestion in the quoted
nimal experiments always was acute and short-lived while in
atients admitted with ADHF venous congestion most often arises olowly and gradually over the preceding weeks. Second, some of
ur patients have been treated with long-term neurohormonal
ntagonists and may have pre-existing/intrinsic renal dysfunction
ontrary to animal models, which had normal renal function at the
oment venous pressure was artificially raised. Furthermore, other
xtrinsic factors as a result of long-term venous congestion (such as
aised intra-abdominal pressure caused by visceral edema or
scites) may contribute to this cardio-renal pathophysiology (2).
owever, the first step is to recognize that venous congestion is a
ajor feature of the syndrome, which is the primary message of
his and several other recent papers in different patient populations
3,4). We fully agree that more rigorous studies are needed, and we
elieve that the search for future ADHF therapies should focus on
trategies that allow safe and optimal reduction and prevention of
enous congestion to prevent such a devastating complication.
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eply
e appreciate the opportunity to answer the thoughtful letter of
rs. Maqsood and Szerlip, who raised the issues of the role of
igorous diuresis in the patients discussed in the article by Mullens
t al. (1), and the activation of the renin-angiotensin-aldosterone
ystem (RAAS) after ultrafiltration (2).
Our interpretation of the study by Mullens et al. (1) is that the
entral venous pressure decrease in the worsening renal function
WRF) group was not significantly different from that of the
on-WRF group, approximately 35%. Nevertheless, the central
enous pressure remained significantly (p  0.04) higher in the
RF group. We think this supports the hypothesis proposed by
ullens et al. (1) about the important role of venous congestion in
ontributing to WRF.
Our suggestion about the differing activation of the RAAS with
iuretics and ultrafiltration is derived from an elegant study done
ver a decade ago. In 1994, Agostoni et al. (3) demonstrated that
